PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
03-Jun-2024 Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting Grey Wolf Therapeutics
03-Jun-2024 Qlucore starts project after receiving prestigious EU grant to advance personalized cancer treatment Qlucore
03-Jun-2024 STORM Therapeutics Presented Interim Phase 1 Clinical Data on its METTL3 RNA Methyltransferase Inhibitor STC-15 at ASCO 2024 STORM Therapeutics
03-Jun-2024 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine HUTCHMED
03-Jun-2024 Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer Transgene
03-Jun-2024 Leading Biopharmaceutical Companies Unite to Advance SCE with Domino Domino Data Lab
03-Jun-2024 SK pharmteco et ART-TG accueillent le premier symposium international Momentum in Cell & Gene Therapy en France Andrew Lloyd Associates
31-May-2024 Anocca Appoints Christiane Hanke-Harloff to Board of Directors Anocca
30-May-2024 Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals Nxera Pharma
30-May-2024 New boost for TechBio companies seeking investment The UK Bioindustry Association (BIA)
30-May-2024 Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology Anocca AB
30-May-2024 POA Pharma announces expansion into Austria, deepening its inborn metabolic disease footprint in Europe Galen Ltd
30-May-2024 Genomics Market Size To Reach $94.86 Billion By 2030 | CAGR: 16.5% Grand View Research, Inc.
30-May-2024 CD Genomics Redefines the Boundaries of Fungal Genomics with Innovative De Novo Sequencing Solutions CD Genomics
29-May-2024 Asymchem Welcomes Franck Mevellec as Senior Director, Business Development Asymchem
29-May-2024 The Department of Health – Abu Dhabi and Eli Lilly Suisse S.A to collaborate to advance Neurodegenerative Disease patient care in the Emirate The Department of Health – Abu Dhabi
29-May-2024 Lexicon Pharmaceuticals Selects Medidata to Help Advance First Non-Opioid Drug for Neuropathic Pain in Over Two Decades Lexicon Pharmaceuticals
29-May-2024 ScaleReady announces $20 Million G-Rex® grant program for the advancement of cell and gene therapy (CGT) development and manufacturing CellReady LLC
29-May-2024 NowPatient Expands Services with Pharmacogenetics Testing Deals in the US and Germany NowPatient
29-May-2024 Resolution Therapeutics Announces Upcoming Scientific Presentations at EASL Congress 2024 Resolution Therapeutics